Ironwood Pharmaceuticals Inc financial data

Symbol
IRWD on Nasdaq
Industry
Pharmaceutical Preparations
Location
100 Summer Street, Suite 2300, Boston, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 128 % -63.3%
Return On Equity 0.75 %
Return On Assets -0.58 % +99.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 160M shares +2.5%
Common Stock, Shares, Outstanding 160M shares +2.49%
Entity Public Float 1.47B USD -5.77%
Common Stock, Value, Issued 160K USD +2.56%
Weighted Average Number of Shares Outstanding, Basic 160M shares +2.45%
Weighted Average Number of Shares Outstanding, Diluted 160M shares -14.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 378M USD -12.5%
Research and Development Expense 122M USD +34%
Costs and Expenses 279M USD -79.3%
Operating Income (Loss) 99.2M USD -35.9%
Nonoperating Income (Expense) -27.7M USD -426%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 71.6M USD -45.6%
Income Tax Expense (Benefit) 74.7M USD -0.13%
Net Income (Loss) Attributable to Parent -2.46M USD +99.7%
Earnings Per Share, Basic -0.03 USD/shares +99.5%
Earnings Per Share, Diluted -0.03 USD/shares +99.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 88.2M USD -19.9%
Accounts Receivable, after Allowance for Credit Loss, Current 76.2M USD -38.8%
Assets, Current 179M USD -29.6%
Deferred Income Tax Assets, Net 185M USD -23.9%
Property, Plant and Equipment, Net 4.8M USD -14.8%
Operating Lease, Right-of-Use Asset 11.4M USD -11.8%
Other Assets, Noncurrent 6.29M USD +64.4%
Assets 390M USD -25.7%
Accounts Payable, Current 3.24M USD -31.1%
Employee-related Liabilities, Current 15.5M USD -38%
Contract with Customer, Liability, Current 1.9M USD -26.9%
Liabilities, Current 49.4M USD -82.4%
Operating Lease, Liability, Noncurrent 12.9M USD -14.5%
Other Liabilities, Noncurrent 39.8M USD +28.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.05M USD -173%
Retained Earnings (Accumulated Deficit) -1.7B USD -0.15%
Stockholders' Equity Attributable to Parent -311M USD +3.68%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -311M USD +4.41%
Liabilities and Equity 390M USD -25.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 45M USD -43.9%
Net Cash Provided by (Used in) Financing Activities -15.6M USD -491%
Net Cash Provided by (Used in) Investing Activities -68K USD
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 160M shares +2.49%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 29.4M USD -65.1%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 88.2M USD -20.9%
Deferred Tax Assets, Valuation Allowance 85.6M USD +2704%
Deferred Tax Assets, Gross 301M USD +3.74%
Operating Lease, Liability 16.1M USD -11.7%
Depreciation 513K USD +79.4%
Payments to Acquire Property, Plant, and Equipment 68K USD +423%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -3.7M USD +99.6%
Lessee, Operating Lease, Liability, to be Paid 18.8M USD -14.2%
Property, Plant and Equipment, Gross 14.5M USD -15.1%
Operating Lease, Liability, Current 3.17M USD +1.99%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.25M USD +1.98%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.19M USD +2.02%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Deferred Income Tax Expense (Benefit) 14.7M USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.78M USD -26.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.32M USD +2%
Deferred Tax Assets, Operating Loss Carryforwards 105M USD +18.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 75M shares 0%
Unrecognized Tax Benefits 98.2M USD -4.29%
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.38M USD +2.02%
Operating Lease, Payments 773K USD +2.11%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 34M USD -41.5%
Interest Expense 27.3M USD +303%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%